Literature DB >> 25556548

Role of radiation therapy for non-extremity soft tissue sarcomas.

Karen De Amorim Bernstein1, Thomas F Delaney.   

Abstract

BACKGROUND: Negative surgical margins are uncommon for non-extremity soft tissue sarcomas. Radiation therapy is usually recommended to improve local control; however, appropriate RT dosing is challenging due to nearby dose-limiting normal structures.
MATERIAL AND METHODS: Comprehensive literature search using PubMed (March 2014).
RESULTS: Data suggest radiation therapy is an important modality in maximizing local tumor control in non-extremity sarcomas.
CONCLUSION: The literature supports the use of RT to improve local control for non-extremity soft tissue sarcomas.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Head and neck sarcomas; abdominal wall sarcomas; chest wall sarcomas; paraspinal sarcomas; retroperitoneal sarcomas

Mesh:

Year:  2014        PMID: 25556548     DOI: 10.1002/jso.23863

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

1.  Radiation Therapy in Primary Soft Tissue Sarcoma of the Superficial Trunk.

Authors:  Minsi Zhang; Aimee Crago; Sam S Yoon; Samuel Singer; Kaled Alektiar
Journal:  Ann Surg Oncol       Date:  2021-10-15       Impact factor: 4.339

Review 2.  [Complex pelvic and sarcoma surgery with vascular replacement].

Authors:  S Pistorius; Ch Reeps; J Weitz
Journal:  Chirurg       Date:  2016-02       Impact factor: 0.955

3.  A multidisciplinary approach to giant soft tissue sarcoma of the chest wall: A case report.

Authors:  Catherine H Davis; Halim Yammine; Puja G Khaitan; Edward Y Chan; Min P Kim
Journal:  Int J Surg Case Rep       Date:  2016-10-04

4.  Clinical outcomes of tissue expanders on adjuvant radiotherapy of resected retroperitoneal sarcoma.

Authors:  Jeong Il Yu; Do Hoon Lim; Hee Chul Park; Heerim Nam; Bo Kyoung Kim; Sung-Joo Kim; Jae Berm Park
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.